As the world reeled from at the outset of the global COVID-19 pandemic, our firm worked deeply to strategize what we should do for society. Through those sessions in conjunction with ARCH Ventures, the thesis emerged that we needed to remedy critical vulnerabilities in medical supply chains. Together, Bob Nelsen and Joe Lonsdale founded Resilience and raised $800MM to create capabilities and capacity to rapidly produce and distribute important drugs at scale. Together, we amassed top executives, Board of Directors, and advisors with experience at the highest levels of business, the biopharmaceutical industry, academia, and government, including:– Rahul Singhvi, Sc.D. — CEO; former Operating Partner at Flagship Pioneering; COO of Takeda Vaccines; CEO of Novavax– Sandy Mahatme, LL.M. — President, COO & CFO; former CFO and Chief Business Officer at Sarepta Therapeutics; SVP Finance & Corporate Development at Celgene– Patrick Y. Yang, Ph.D. — Vice Chairman; former EVP at Juno Therapeutics; EVP & Global Head of Technical Operations at Roche/GenentechDirectors and Advisors include luminaries such as Frances Arnold, the Nobel Prize-winning professor from the California Institute of Technology; George Barrett, the former chief executive of Cardinal Health; Susan Desmond-Hellmann, the former president of product development at Genentech; Kaye Foster, the former vice president of human resources at Johnson and Johnson; and Denice Torres, the former president of Johnson & Johnson Pharmaceutical and Consumer Companies; and more.